Works matching AU Peng-yu Zhang


Results: 20
    1
    2
    3
    4
    5
    6
    7

    Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report.

    Published in:
    2022
    By:
    • Wang, Bai-Yan;
    • Zhao, Wan-Hong;
    • Chen, Yin-Xia;
    • Cao, Xing-Mei;
    • Yang, Yun;
    • Zhang, Yi-Lin;
    • Wang, Fang-Xia;
    • Zhang, Peng-Yu;
    • Lei, Bo;
    • Gu, Liu-Fang;
    • Wang, Jian-Li;
    • Bai, Ju;
    • Xu, Yan;
    • Wang, Xu-Geng;
    • Zhang, Rui-Li;
    • Wei, Li-Li;
    • Zhuang, Qiu-Chuan;
    • Fan, Frank;
    • Zhang, Wang-Gang;
    • He, Ai-Li
    Publication type:
    Case Study
    8

    Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2).

    Published in:
    Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01301-8
    By:
    • Zhao, Wan-Hong;
    • Wang, Bai-Yan;
    • Chen, Li-Juan;
    • Fu, Wei-Jun;
    • Xu, Jie;
    • Liu, Jie;
    • Jin, Shi-Wei;
    • Chen, Yin-Xia;
    • Cao, Xing-Mei;
    • Yang, Yun;
    • Zhang, Yi-Lin;
    • Wang, Fang-Xia;
    • Zhang, Peng-Yu;
    • Lei, Bo;
    • Gu, Liu-Fang;
    • Wang, Jian-Li;
    • Zhang, Hui;
    • Bai, Ju;
    • Xu, Yan;
    • Zhu, Han
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Induction of apoptosis by Hax-1 siRNA in melanoma cells

    Published in:
    Cell Biology International, 2009, v. 33, n. 4, p. 548, doi. 10.1016/j.cellbi.2009.02.005
    By:
    • Li, Wen-Bin;
    • Feng, Jie;
    • Geng, Song-Mei;
    • Zhang, Peng-Yu;
    • Yan, Xiao-Ning;
    • Hu, Gang;
    • Zhang, Cai-Qing;
    • Shi, Bing-Jun
    Publication type:
    Article
    15
    16

    A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma.

    Published in:
    Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. 1, doi. 10.1186/s13045-018-0681-6
    By:
    • Wan-Hong Zhao;
    • Jie Liu;
    • Bai-Yan Wang;
    • Yin-Xia Chen;
    • Xing-Mei Cao;
    • Yun Yang;
    • Yi-Lin Zhang;
    • Fang-Xia Wang;
    • Peng-Yu Zhang;
    • Bo Lei;
    • Liu-Fang Gu;
    • Jian-Li Wang;
    • Nan Yang;
    • Ru Zhang;
    • Hui Zhang;
    • Ying Shen;
    • Ju Bai;
    • Yan Xu;
    • Xu-Geng Wang;
    • Rui-Li Zhang
    Publication type:
    Article
    17
    18
    19
    20